Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases — Is There Any Benefit of PAH-specific Therapy?

Advances in Respiratory Medicine - Poland
doi 10.5603/arm.2017.0036
Full Text
Abstract

Available in full text

Date
Authors
Publisher

VM Media SP. zo.o VM Group SK

Related search

Diffuse Parenchymal Lung Disease

European Respiratory Review
PulmonaryRespiratory Medicine
2017English

Restaging Patients With Locoregional Relapse: Is There Any Benefit?

Annals of Surgical Oncology
OncologySurgery
2019English

Transbronchial Cryobiopsy Validity in Diagnosing Diffuse Parenchymal Lung Diseases in Egyptian Population

Journal of Multidisciplinary Healthcare
MedicineNursing
2019English

Withdrawal of Long-Term Epoprostenol Therapy in Pulmonary Arterial Hypertension (PAH)

Pulmonary Circulation
PulmonaryRespiratory Medicine
2017English

Risk and Benefit of Lung Biopsy in Primary Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
1990English

Hot Tub Lung: An Intriguing Diffuse Parenchymal Lung Disease

Ghana Medical Journal
Medicine
2017English

Diagnostic Yield and Safety of Cryoprobe Transbronchial Lung Biopsy in Diffuse Parenchymal Lung Diseases: Systematic Review and Meta-Analysis

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

Protective Lung Ventilation During General Anesthesia: Is There Any Evidence?

Critical Care
Critical CareIntensive Care Medicine
2014English

Successful Titration of Triple Oral Therapy in a Patient With Pulmonary Arterial Hypertension (PAH)

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy